Structure

Xamoterol hemifumarate

CAS
73210-73-8
Catalog Number
ACM73210738
Category
Main Products
Molecular Weight
794.85
Molecular Formula
C36H54N6O14

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide
Appearance
Crystalline solid

Xamoterol Hemifumarate as a Beta-1 Adrenoceptor Agonist for Dissecting Adipocyte Recruitment versus Transdifferentiation in White Adipose Tissue

Immunohistochemical images showing UCP1-positive paucilocular and multilocular brown adipocytes in mouse subcutaneous white adipose tissue following cold exposure and selective adrenoceptor agonist treatment. Barbatelli, G., et al. (2010). Am. J. Physiol. Endocrinol. Metab., 298, E1244-E1253.

Xamoterol hemifumarate serves as a selective beta1-adrenoceptor agonist to distinguish preadipocyte recruitment from white-to-brown adipocyte transdifferentiation in murine white adipose tissue upon cold stress, providing mechanistic insight into adipose plasticity.
Experimental Protocol: Female 129Sv mice received daily intraperitoneal injections of xamoterol hemifumarate (0.144 mg/kg) or the beta3-adrenoceptor agonist CL316,243 (0.1 mg/kg) for 3 or 5 days at room temperature. Subcutaneous white adipose tissue was harvested and processed for light microscopy, immunohistochemistry with anti-UCP1 antibody, and electron microscopy. Morphometric analysis quantified unilocular, paucilocular, and multilocular adipocytes, with preadipocyte density expressed as number per 100 adipocytes.
Performance Evaluation: Xamoterol administration increased only the number of preadipocytes in white adipose tissue, whereas CL316,243 induced the appearance of UCP1-immunoreactive brown adipocytes displaying paucilocular morphology. Cold exposure at 6 degrees C for 10 days increased brown adipocytes by 20-fold in subcutaneous white adipose tissue of wild-type mice, an effect that was blunted in beta3-adrenoceptor knockout animals. These findings demonstrate that beta1-adrenoceptor stimulation selectively mediates preadipocyte recruitment while beta3-adrenoceptor activation governs transdifferentiation of mature white adipocytes into brown adipocytes.

Xamoterol Hemifumarate as a Weak Partial Beta-1 Adrenoceptor Agonist for Validating Endogenous Promoter-Driven Split Luciferase G Protein Biosensors

Concentration-response curves showing xamoterol as a weak partial agonist at beta1AR-NlucC and as an antagonist at beta2AR-NlucC in HEK293T cell-based split luciferase complementation assays. Humphrys, L.J., et al. (2024). bioRxiv, doi: 10.1101/2024.06.03.597093.

Xamoterol hemifumarate functions as a pharmacological probe to characterize beta-adrenoceptor subtype selectivity in a split nanoluciferase complementation-based mini-G protein recruitment assay using CRISPR/Cas9-modified HEK293T cells expressing tagged receptors at endogenous levels.
Experimental Protocol: HEK293T cells were genetically engineered using plasmid-based CRISPR/Cas9 to tag endogenous beta1- and beta2-adrenoceptors with NlucC fragments while replacing Galphas with NlucN-tagged minimal Gs protein. Concentration-response curves for xamoterol and standard agonists were generated in both overexpressed and CRISPR-modified native expression systems. Ligand-induced complementation of split luciferase fragments upon receptor-G protein interaction restored catalytic activity, producing bioluminescence upon furimazine substrate oxidation.
Performance Evaluation: In overexpressed systems, xamoterol acted as an antagonist at beta2-adrenoceptors but displayed weak partial agonist activity at beta1-adrenoceptors with a maximal efficacy of 14 plus-minus 1 percent relative to adrenaline. In the CRISPR/Cas9-modified endogenous system, xamoterol plateaued at a significantly higher level than with overexpression, enabling more accurate discrimination of partial agonist behavior. These results demonstrate that native receptor expression levels critically influence the pharmacological characterization of partial agonists.

What is the molecular formula of Xamoterol hemifumarate?

The molecular formula of Xamoterol hemifumarate is C36H54N6O14.

What is the molecular weight of Xamoterol hemifumarate?

The molecular weight of Xamoterol hemifumarate is 794.8 g/mol.

What is the IUPAC name of Xamoterol hemifumarate?

The IUPAC name of Xamoterol hemifumarate is (E)-but-2-enedioic acid;N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide.

What is the InChIKey of Xamoterol hemifumarate?

The InChIKey of Xamoterol hemifumarate is QEDVGROSOZBGOZ-WXXKFALUSA-N.

What is the canonical SMILES of Xamoterol hemifumarate?

The canonical SMILES of Xamoterol hemifumarate is C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O.C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O.C(=CC(=O)O)C(=O)O.

What is the CAS number of Xamoterol hemifumarate?

The CAS number of Xamoterol hemifumarate is 73210-73-8.

How many hydrogen bond donor counts does Xamoterol hemifumarate have?

Xamoterol hemifumarate has 10 hydrogen bond donor counts.

How many hydrogen bond acceptor counts does Xamoterol hemifumarate have?

Xamoterol hemifumarate has 16 hydrogen bond acceptor counts.

How many rotatable bond counts does Xamoterol hemifumarate have?

Xamoterol hemifumarate has 18 rotatable bond counts.

What is the topological polar surface area of Xamoterol hemifumarate?

The topological polar surface area of Xamoterol hemifumarate is 281Ų.

Please kindly note that our products are for research use only.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
Loading...
Loading...
Download PDF documentDownload
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.